Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Apolipoproteins | 23 | 2024 | 327 | 3.790 |
Why?
|
Kidney Diseases | 20 | 2024 | 2092 | 3.190 |
Why?
|
Lipoproteins, HDL | 21 | 2024 | 675 | 3.140 |
Why?
|
Glomerulosclerosis, Focal Segmental | 14 | 2024 | 335 | 2.140 |
Why?
|
Renal Insufficiency, Chronic | 14 | 2022 | 2254 | 2.000 |
Why?
|
Apyrase | 6 | 2009 | 373 | 0.950 |
Why?
|
Kidney Failure, Chronic | 8 | 2020 | 2478 | 0.900 |
Why?
|
Trypanosomiasis, African | 5 | 2017 | 30 | 0.880 |
Why?
|
Genetic Predisposition to Disease | 24 | 2024 | 17897 | 0.820 |
Why?
|
Adenosine Deaminase | 1 | 2022 | 250 | 0.710 |
Why?
|
Interferon Type I | 1 | 2022 | 557 | 0.620 |
Why?
|
Polymorphism, Single Nucleotide | 12 | 2024 | 15920 | 0.620 |
Why?
|
Saccharum | 1 | 2018 | 20 | 0.610 |
Why?
|
Mitochondrial Membrane Transport Proteins | 1 | 2019 | 158 | 0.610 |
Why?
|
Renal Insufficiency | 2 | 2016 | 808 | 0.610 |
Why?
|
AIDS-Associated Nephropathy | 5 | 2021 | 34 | 0.590 |
Why?
|
Hyperuricemia | 2 | 2018 | 222 | 0.590 |
Why?
|
Central America | 3 | 2024 | 69 | 0.530 |
Why?
|
Tattooing | 1 | 2016 | 57 | 0.530 |
Why?
|
Antigens, CD | 6 | 2009 | 4009 | 0.520 |
Why?
|
Glomerulonephritis | 1 | 2018 | 333 | 0.510 |
Why?
|
Kidney | 9 | 2024 | 7033 | 0.490 |
Why?
|
Receptors, Purinergic P2X7 | 1 | 2015 | 86 | 0.470 |
Why?
|
Diabetic Nephropathies | 3 | 2020 | 973 | 0.470 |
Why?
|
Cosmetic Techniques | 1 | 2016 | 147 | 0.460 |
Why?
|
Genetic Variation | 11 | 2020 | 6567 | 0.460 |
Why?
|
Immunity, Innate | 3 | 2017 | 3044 | 0.460 |
Why?
|
Lasers, Solid-State | 1 | 2016 | 176 | 0.460 |
Why?
|
Trypanosoma brucei gambiense | 1 | 2013 | 8 | 0.450 |
Why?
|
Evolution, Molecular | 2 | 2020 | 1882 | 0.410 |
Why?
|
Rural Population | 7 | 2011 | 2277 | 0.400 |
Why?
|
Glaucoma, Angle-Closure | 5 | 2012 | 191 | 0.400 |
Why?
|
Glaucoma, Open-Angle | 5 | 2012 | 739 | 0.370 |
Why?
|
Podocytes | 4 | 2022 | 398 | 0.360 |
Why?
|
Refractive Errors | 2 | 2009 | 148 | 0.360 |
Why?
|
Amblyopia | 2 | 2010 | 152 | 0.360 |
Why?
|
Genotype | 12 | 2023 | 12985 | 0.350 |
Why?
|
Occupational Diseases | 1 | 2018 | 1490 | 0.340 |
Why?
|
Acute Kidney Injury | 2 | 2020 | 1923 | 0.330 |
Why?
|
Biological Evolution | 2 | 2014 | 1075 | 0.330 |
Why?
|
Sequence Deletion | 3 | 2010 | 1487 | 0.320 |
Why?
|
Hypertension | 5 | 2020 | 8536 | 0.300 |
Why?
|
Africa | 4 | 2020 | 714 | 0.300 |
Why?
|
Glucuronidase | 1 | 2009 | 202 | 0.300 |
Why?
|
Proteinuria | 3 | 2024 | 605 | 0.300 |
Why?
|
Gene Frequency | 9 | 2016 | 3603 | 0.290 |
Why?
|
Kidney Glomerulus | 4 | 2021 | 567 | 0.290 |
Why?
|
Humans | 92 | 2024 | 761208 | 0.290 |
Why?
|
Interferons | 2 | 2022 | 702 | 0.270 |
Why?
|
Genome-Wide Association Study | 2 | 2024 | 12676 | 0.270 |
Why?
|
Risk Factors | 32 | 2024 | 74239 | 0.270 |
Why?
|
HEK293 Cells | 7 | 2023 | 4243 | 0.260 |
Why?
|
Strabismus | 2 | 2010 | 317 | 0.260 |
Why?
|
Animals | 29 | 2024 | 168079 | 0.240 |
Why?
|
Mice | 20 | 2024 | 81326 | 0.240 |
Why?
|
Lisinopril | 1 | 2024 | 60 | 0.230 |
Why?
|
Haplotypes | 4 | 2019 | 2715 | 0.230 |
Why?
|
Homeostasis | 1 | 2015 | 3320 | 0.220 |
Why?
|
Glomerular Filtration Rate | 3 | 2022 | 2182 | 0.220 |
Why?
|
Renal Dialysis | 2 | 2011 | 1796 | 0.220 |
Why?
|
Prevalence | 16 | 2018 | 15721 | 0.220 |
Why?
|
Evoked Potentials | 1 | 2009 | 1047 | 0.220 |
Why?
|
Mental Recall | 1 | 2009 | 1221 | 0.210 |
Why?
|
Creatinine | 4 | 2023 | 1897 | 0.210 |
Why?
|
Nicaragua | 3 | 2019 | 29 | 0.210 |
Why?
|
Age Distribution | 9 | 2011 | 2871 | 0.210 |
Why?
|
Alleles | 7 | 2020 | 6857 | 0.200 |
Why?
|
Cross-Sectional Studies | 21 | 2020 | 26071 | 0.200 |
Why?
|
Inosine | 1 | 2022 | 129 | 0.200 |
Why?
|
Blood Glucose | 4 | 2015 | 6392 | 0.200 |
Why?
|
Adenosine | 2 | 2022 | 805 | 0.200 |
Why?
|
Molecular Motor Proteins | 4 | 2015 | 106 | 0.200 |
Why?
|
Mice, Knockout | 6 | 2024 | 14392 | 0.200 |
Why?
|
Diabetic Angiopathies | 1 | 2007 | 805 | 0.200 |
Why?
|
Photography | 4 | 2012 | 532 | 0.200 |
Why?
|
Maternal Deprivation | 2 | 2012 | 48 | 0.190 |
Why?
|
Crohn Disease | 2 | 2011 | 2278 | 0.190 |
Why?
|
Trabecular Meshwork | 2 | 2012 | 101 | 0.190 |
Why?
|
Sex Distribution | 7 | 2010 | 2277 | 0.190 |
Why?
|
RNA Editing | 1 | 2022 | 149 | 0.190 |
Why?
|
RNA, Double-Stranded | 1 | 2022 | 290 | 0.190 |
Why?
|
Male | 49 | 2024 | 360693 | 0.180 |
Why?
|
Colitis | 1 | 2009 | 1234 | 0.180 |
Why?
|
Insulin Resistance | 2 | 2012 | 3952 | 0.180 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2007 | 1116 | 0.180 |
Why?
|
Myosin Heavy Chains | 4 | 2015 | 403 | 0.180 |
Why?
|
3' Untranslated Regions | 1 | 2022 | 514 | 0.180 |
Why?
|
Polymorphism, Genetic | 2 | 2014 | 4243 | 0.170 |
Why?
|
Adult | 33 | 2024 | 221119 | 0.170 |
Why?
|
Glucosides | 1 | 2024 | 512 | 0.170 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2015 | 12159 | 0.170 |
Why?
|
Mice, Transgenic | 5 | 2024 | 9520 | 0.170 |
Why?
|
Heredity | 1 | 2020 | 148 | 0.160 |
Why?
|
Balkan Nephropathy | 1 | 2019 | 1 | 0.160 |
Why?
|
Colitis, Ulcerative | 1 | 2011 | 1920 | 0.160 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2018 | 4574 | 0.160 |
Why?
|
Mining | 1 | 2019 | 93 | 0.160 |
Why?
|
Cell Respiration | 1 | 2019 | 201 | 0.160 |
Why?
|
Female | 46 | 2024 | 392544 | 0.160 |
Why?
|
Trypanosoma brucei rhodesiense | 3 | 2016 | 13 | 0.150 |
Why?
|
Vitamin D | 1 | 2012 | 3301 | 0.150 |
Why?
|
Uromodulin | 1 | 2018 | 44 | 0.150 |
Why?
|
Gonioscopy | 3 | 2012 | 155 | 0.150 |
Why?
|
Genetic Association Studies | 4 | 2019 | 2731 | 0.150 |
Why?
|
Baltimore | 4 | 2011 | 231 | 0.150 |
Why?
|
Receptors, OX40 | 1 | 2017 | 46 | 0.150 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2024 | 1504 | 0.140 |
Why?
|
Benzhydryl Compounds | 1 | 2024 | 917 | 0.140 |
Why?
|
Macular Degeneration | 2 | 2004 | 1008 | 0.140 |
Why?
|
Proteoglycans | 1 | 2020 | 803 | 0.140 |
Why?
|
Serum Albumin | 2 | 2013 | 674 | 0.140 |
Why?
|
Cell Death | 2 | 2019 | 1676 | 0.140 |
Why?
|
Mutation, Missense | 2 | 2016 | 2567 | 0.140 |
Why?
|
China | 7 | 2011 | 2374 | 0.140 |
Why?
|
Intraocular Pressure | 6 | 2012 | 1294 | 0.130 |
Why?
|
Ubiquitins | 1 | 2018 | 366 | 0.130 |
Why?
|
RNA, Messenger | 3 | 2022 | 12747 | 0.130 |
Why?
|
Middle Aged | 32 | 2020 | 220853 | 0.130 |
Why?
|
Aged | 29 | 2019 | 169288 | 0.130 |
Why?
|
Visually Impaired Persons | 2 | 2009 | 78 | 0.130 |
Why?
|
HIV Infections | 1 | 2022 | 17347 | 0.130 |
Why?
|
Color | 1 | 2016 | 297 | 0.120 |
Why?
|
Optic Nerve Diseases | 2 | 2012 | 342 | 0.120 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2020 | 610 | 0.120 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2009 | 2421 | 0.120 |
Why?
|
Hyperopia | 2 | 2011 | 41 | 0.120 |
Why?
|
Ion Transport | 1 | 2015 | 319 | 0.120 |
Why?
|
Anterior Chamber | 2 | 2012 | 194 | 0.120 |
Why?
|
Disease Models, Animal | 5 | 2024 | 18220 | 0.120 |
Why?
|
Case-Control Studies | 7 | 2019 | 22174 | 0.120 |
Why?
|
Pedigree | 2 | 2020 | 4537 | 0.120 |
Why?
|
Protein Multimerization | 1 | 2019 | 974 | 0.120 |
Why?
|
Astigmatism | 2 | 2011 | 68 | 0.110 |
Why?
|
Interferon-gamma | 1 | 2022 | 3155 | 0.110 |
Why?
|
Gene Duplication | 1 | 2015 | 314 | 0.110 |
Why?
|
Toll-Like Receptor 3 | 1 | 2014 | 97 | 0.110 |
Why?
|
Protein Transport | 1 | 2019 | 1958 | 0.110 |
Why?
|
Visual Acuity | 6 | 2010 | 2676 | 0.110 |
Why?
|
Diagnostic Techniques, Ophthalmological | 2 | 2012 | 251 | 0.110 |
Why?
|
Meta-Analysis as Topic | 1 | 2018 | 1381 | 0.100 |
Why?
|
Environment | 1 | 2019 | 1122 | 0.100 |
Why?
|
Proteomics | 2 | 2020 | 3840 | 0.100 |
Why?
|
Antiporters | 2 | 2004 | 276 | 0.100 |
Why?
|
Aged, 80 and over | 19 | 2012 | 58952 | 0.100 |
Why?
|
Hydroxyindoleacetic Acid | 1 | 2012 | 93 | 0.100 |
Why?
|
Immunotherapy | 2 | 2018 | 4642 | 0.100 |
Why?
|
Recombinant Proteins | 3 | 2019 | 6504 | 0.100 |
Why?
|
Ambulatory Care Facilities | 1 | 2018 | 934 | 0.100 |
Why?
|
Myopia | 2 | 2011 | 252 | 0.100 |
Why?
|
Lupus Nephritis | 1 | 2015 | 317 | 0.100 |
Why?
|
Phenotype | 5 | 2020 | 16575 | 0.100 |
Why?
|
Occupational Health | 1 | 2018 | 807 | 0.100 |
Why?
|
Visual Fields | 5 | 2012 | 1059 | 0.100 |
Why?
|
Haploidy | 1 | 2011 | 126 | 0.100 |
Why?
|
Potassium | 1 | 2015 | 1309 | 0.100 |
Why?
|
Anterior Eye Segment | 1 | 2012 | 143 | 0.090 |
Why?
|
Aging | 2 | 2009 | 8702 | 0.090 |
Why?
|
Linkage Disequilibrium | 3 | 2013 | 1994 | 0.090 |
Why?
|
Exfoliation Syndrome | 1 | 2012 | 113 | 0.090 |
Why?
|
RNA Interference | 1 | 2019 | 2816 | 0.090 |
Why?
|
Autophagy | 1 | 2019 | 1327 | 0.090 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2015 | 1240 | 0.090 |
Why?
|
Iris | 1 | 2011 | 231 | 0.090 |
Why?
|
Diabetic Retinopathy | 2 | 2011 | 1276 | 0.090 |
Why?
|
RNA, Small Interfering | 1 | 2019 | 3412 | 0.090 |
Why?
|
Blindness | 2 | 2004 | 585 | 0.090 |
Why?
|
Nutrition Surveys | 1 | 2016 | 1723 | 0.080 |
Why?
|
Mice, Inbred C57BL | 6 | 2024 | 22127 | 0.080 |
Why?
|
Disease Progression | 5 | 2018 | 13511 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 4 | 2015 | 6486 | 0.080 |
Why?
|
Epiretinal Membrane | 1 | 2008 | 73 | 0.080 |
Why?
|
Macaca mulatta | 2 | 2012 | 2328 | 0.080 |
Why?
|
Linear Models | 1 | 2018 | 5869 | 0.080 |
Why?
|
Analysis of Variance | 3 | 2012 | 6223 | 0.070 |
Why?
|
Nerve Degeneration | 1 | 2012 | 747 | 0.070 |
Why?
|
Liver | 2 | 2016 | 7514 | 0.070 |
Why?
|
Time Factors | 6 | 2017 | 39957 | 0.070 |
Why?
|
Glomerular Mesangium | 1 | 2007 | 98 | 0.070 |
Why?
|
Serotonin | 1 | 2012 | 1042 | 0.070 |
Why?
|
Streptozocin | 1 | 2007 | 193 | 0.070 |
Why?
|
Tomography, Optical Coherence | 4 | 2012 | 2923 | 0.070 |
Why?
|
Tonometry, Ocular | 3 | 2012 | 236 | 0.070 |
Why?
|
Singapore | 3 | 2012 | 292 | 0.070 |
Why?
|
Functional Laterality | 2 | 2010 | 2257 | 0.070 |
Why?
|
DNA Copy Number Variations | 1 | 2015 | 2024 | 0.070 |
Why?
|
Amino Acid Sequence | 2 | 2016 | 13402 | 0.070 |
Why?
|
Public Health | 1 | 2019 | 2672 | 0.070 |
Why?
|
5'-Nucleotidase | 1 | 2007 | 161 | 0.060 |
Why?
|
Fasting | 1 | 2012 | 1603 | 0.060 |
Why?
|
Molecular Targeted Therapy | 1 | 2017 | 2813 | 0.060 |
Why?
|
Kidney Tubules | 1 | 2008 | 448 | 0.060 |
Why?
|
Ethanol | 1 | 2012 | 1322 | 0.060 |
Why?
|
Renin | 1 | 2008 | 639 | 0.060 |
Why?
|
Gene Products, tat | 2 | 1995 | 111 | 0.060 |
Why?
|
Genome, Human | 3 | 2015 | 4423 | 0.060 |
Why?
|
Kidney Transplantation | 1 | 2020 | 4242 | 0.060 |
Why?
|
Liver Transplantation | 1 | 2016 | 2332 | 0.060 |
Why?
|
Pilot Projects | 1 | 2018 | 8642 | 0.060 |
Why?
|
Chloride-Bicarbonate Antiporters | 1 | 2004 | 103 | 0.060 |
Why?
|
Mutation | 4 | 2019 | 30002 | 0.060 |
Why?
|
Young Adult | 8 | 2020 | 59221 | 0.060 |
Why?
|
Transforming Growth Factor beta | 1 | 2012 | 1963 | 0.060 |
Why?
|
Cornea | 1 | 2012 | 1327 | 0.060 |
Why?
|
Osteosarcoma | 1 | 2010 | 896 | 0.060 |
Why?
|
Epidemiologic Methods | 1 | 2009 | 1336 | 0.060 |
Why?
|
Head and Neck Neoplasms | 1 | 2018 | 2894 | 0.060 |
Why?
|
Pseudophakia | 1 | 2004 | 60 | 0.060 |
Why?
|
Aphakia, Postcataract | 1 | 2004 | 52 | 0.060 |
Why?
|
Health Status Disparities | 1 | 2015 | 1847 | 0.060 |
Why?
|
Genomics | 1 | 2020 | 5828 | 0.060 |
Why?
|
Blood Pressure | 3 | 2024 | 8479 | 0.060 |
Why?
|
Behavior, Animal | 1 | 2011 | 1873 | 0.050 |
Why?
|
Retinal Diseases | 1 | 2009 | 705 | 0.050 |
Why?
|
Age of Onset | 3 | 2019 | 3307 | 0.050 |
Why?
|
Molecular Sequence Data | 3 | 2014 | 17598 | 0.050 |
Why?
|
Eye Diseases | 1 | 2009 | 653 | 0.050 |
Why?
|
Hypertonic Solutions | 1 | 2003 | 82 | 0.050 |
Why?
|
Reaction Time | 1 | 2009 | 2087 | 0.050 |
Why?
|
Egtazic Acid | 1 | 2003 | 166 | 0.050 |
Why?
|
Human Genome Project | 2 | 2015 | 200 | 0.050 |
Why?
|
Body Composition | 1 | 2012 | 2427 | 0.050 |
Why?
|
Databases, Factual | 1 | 2018 | 7966 | 0.050 |
Why?
|
Vitamin D Deficiency | 1 | 2012 | 1388 | 0.050 |
Why?
|
Models, Genetic | 1 | 2012 | 3430 | 0.050 |
Why?
|
Diacylglycerol O-Acyltransferase | 1 | 2022 | 20 | 0.050 |
Why?
|
Quaternary Ammonium Compounds | 1 | 2003 | 202 | 0.050 |
Why?
|
Anion Transport Proteins | 1 | 2003 | 141 | 0.050 |
Why?
|
Vision, Low | 1 | 2004 | 163 | 0.050 |
Why?
|
Cohort Studies | 3 | 2014 | 41496 | 0.050 |
Why?
|
United States | 9 | 2015 | 72339 | 0.050 |
Why?
|
B-Lymphocytes | 1 | 2015 | 4744 | 0.050 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2016 | 502 | 0.050 |
Why?
|
Chromosomes, Artificial, Bacterial | 1 | 2021 | 123 | 0.050 |
Why?
|
Adolescent | 7 | 2020 | 88298 | 0.050 |
Why?
|
Atherosclerosis | 2 | 2015 | 3406 | 0.050 |
Why?
|
Cataract | 2 | 2004 | 828 | 0.050 |
Why?
|
Risk Assessment | 3 | 2018 | 24021 | 0.050 |
Why?
|
Los Angeles | 2 | 2011 | 244 | 0.050 |
Why?
|
Aptamers, Peptide | 1 | 2020 | 28 | 0.050 |
Why?
|
Polymerase Chain Reaction | 2 | 2007 | 6067 | 0.050 |
Why?
|
Urban Population | 1 | 2009 | 2036 | 0.050 |
Why?
|
Retinoscopy | 2 | 2011 | 26 | 0.040 |
Why?
|
Chromosomes, Human, Pair 9 | 2 | 2012 | 534 | 0.040 |
Why?
|
Vision Disorders | 1 | 2008 | 1088 | 0.040 |
Why?
|
Child, Preschool | 6 | 2019 | 42224 | 0.040 |
Why?
|
Insulin | 2 | 2012 | 6588 | 0.040 |
Why?
|
Hantavirus Infections | 1 | 2019 | 2 | 0.040 |
Why?
|
Leptospira | 1 | 2019 | 13 | 0.040 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2010 | 4340 | 0.040 |
Why?
|
Sri Lanka | 1 | 2019 | 93 | 0.040 |
Why?
|
Leptospirosis | 1 | 2019 | 31 | 0.040 |
Why?
|
Child | 8 | 2020 | 80152 | 0.040 |
Why?
|
Alcohol Drinking | 1 | 2012 | 4027 | 0.040 |
Why?
|
Membrane Transport Proteins | 1 | 2004 | 1031 | 0.040 |
Why?
|
Heterozygote | 2 | 2015 | 2778 | 0.040 |
Why?
|
Biometry | 2 | 2012 | 563 | 0.040 |
Why?
|
Prognosis | 2 | 2018 | 29687 | 0.040 |
Why?
|
Kidney Function Tests | 1 | 2020 | 680 | 0.040 |
Why?
|
Cytoplasm | 1 | 2003 | 1498 | 0.040 |
Why?
|
Diabetes Mellitus | 3 | 2011 | 5842 | 0.040 |
Why?
|
Ion Channels | 1 | 2022 | 1038 | 0.040 |
Why?
|
Body Mass Index | 2 | 2012 | 12952 | 0.040 |
Why?
|
Bone Neoplasms | 1 | 2010 | 2527 | 0.040 |
Why?
|
Risk | 3 | 2015 | 9616 | 0.040 |
Why?
|
Mice, Inbred C3H | 1 | 2018 | 914 | 0.040 |
Why?
|
False Positive Reactions | 1 | 2019 | 958 | 0.030 |
Why?
|
Anxiety | 1 | 2011 | 4569 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 2014 | 11856 | 0.030 |
Why?
|
Endosomes | 1 | 2019 | 518 | 0.030 |
Why?
|
Stress, Psychological | 1 | 2011 | 4487 | 0.030 |
Why?
|
Cytokine Receptor gp130 | 1 | 2015 | 66 | 0.030 |
Why?
|
Infant | 4 | 2011 | 36169 | 0.030 |
Why?
|
Circular Dichroism | 1 | 2016 | 334 | 0.030 |
Why?
|
Incidence | 4 | 2015 | 21365 | 0.030 |
Why?
|
Hypertension, Renal | 1 | 2015 | 135 | 0.030 |
Why?
|
Lymphocyte Count | 1 | 2017 | 781 | 0.030 |
Why?
|
Signal Transduction | 3 | 2014 | 23416 | 0.030 |
Why?
|
CDC2-CDC28 Kinases | 1 | 1995 | 110 | 0.030 |
Why?
|
Mandrillus | 1 | 2014 | 3 | 0.030 |
Why?
|
Optic Disk | 2 | 2012 | 421 | 0.030 |
Why?
|
Cell Line | 1 | 2008 | 15545 | 0.030 |
Why?
|
Nephritis | 1 | 2015 | 147 | 0.030 |
Why?
|
Neoplasm Transplantation | 1 | 2018 | 2010 | 0.030 |
Why?
|
Brain Mapping | 1 | 2009 | 6635 | 0.030 |
Why?
|
Electroencephalography | 1 | 2009 | 6242 | 0.030 |
Why?
|
Brain | 2 | 2012 | 27092 | 0.030 |
Why?
|
Membrane Proteins | 2 | 2018 | 7851 | 0.030 |
Why?
|
Cell Size | 1 | 2015 | 625 | 0.030 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2007 | 3092 | 0.030 |
Why?
|
Lysosomes | 1 | 2019 | 921 | 0.030 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 1 | 2016 | 509 | 0.030 |
Why?
|
Models, Statistical | 1 | 2008 | 5081 | 0.030 |
Why?
|
Molecular Dynamics Simulation | 1 | 2016 | 427 | 0.030 |
Why?
|
Research Design | 1 | 2009 | 6180 | 0.030 |
Why?
|
Enzyme Activation | 2 | 2015 | 3577 | 0.030 |
Why?
|
Endoplasmic Reticulum | 1 | 2019 | 1125 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2017 | 1867 | 0.030 |
Why?
|
Genes, Recessive | 1 | 2015 | 622 | 0.030 |
Why?
|
Chromatography | 1 | 2012 | 188 | 0.030 |
Why?
|
Papio | 1 | 2014 | 669 | 0.030 |
Why?
|
Geography | 1 | 2014 | 652 | 0.020 |
Why?
|
Ciliary Body | 1 | 2012 | 168 | 0.020 |
Why?
|
Albuminuria | 1 | 2015 | 656 | 0.020 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2016 | 2740 | 0.020 |
Why?
|
Xenopus | 2 | 2004 | 709 | 0.020 |
Why?
|
Retrospective Studies | 2 | 2018 | 80674 | 0.020 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2017 | 1089 | 0.020 |
Why?
|
Ligands | 1 | 2018 | 3264 | 0.020 |
Why?
|
STAT3 Transcription Factor | 1 | 2015 | 872 | 0.020 |
Why?
|
Phosphorylation | 2 | 2015 | 8300 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2015 | 1737 | 0.020 |
Why?
|
Models, Theoretical | 2 | 2014 | 3571 | 0.020 |
Why?
|
Transfection | 2 | 2015 | 5748 | 0.020 |
Why?
|
Anisometropia | 1 | 2010 | 17 | 0.020 |
Why?
|
Homozygote | 1 | 2015 | 1775 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2019 | 4107 | 0.020 |
Why?
|
Trabeculectomy | 1 | 2012 | 174 | 0.020 |
Why?
|
Prospective Studies | 4 | 2019 | 54435 | 0.020 |
Why?
|
Cloning, Molecular | 1 | 2016 | 4167 | 0.020 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2012 | 452 | 0.020 |
Why?
|
Exploratory Behavior | 1 | 2011 | 275 | 0.020 |
Why?
|
Blood Pressure Monitors | 1 | 2010 | 33 | 0.020 |
Why?
|
Biocompatible Materials | 1 | 2018 | 1683 | 0.020 |
Why?
|
Sensory Deprivation | 1 | 2010 | 108 | 0.020 |
Why?
|
Macrophage Migration-Inhibitory Factors | 1 | 2010 | 108 | 0.020 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2010 | 283 | 0.020 |
Why?
|
Obesity | 1 | 2012 | 12939 | 0.020 |
Why?
|
Intramolecular Oxidoreductases | 1 | 2010 | 105 | 0.020 |
Why?
|
Factor Analysis, Statistical | 1 | 2012 | 998 | 0.020 |
Why?
|
Cardiovascular Diseases | 1 | 2015 | 15520 | 0.020 |
Why?
|
Time | 1 | 2011 | 545 | 0.020 |
Why?
|
Calcium | 1 | 2003 | 5719 | 0.020 |
Why?
|
Lysine | 1 | 2014 | 982 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2018 | 6199 | 0.020 |
Why?
|
T-Lymphocyte Subsets | 1 | 2017 | 1803 | 0.020 |
Why?
|
Odds Ratio | 2 | 2011 | 9652 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2017 | 3592 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2004 | 2477 | 0.020 |
Why?
|
Mydriatics | 1 | 2009 | 67 | 0.020 |
Why?
|
Oocytes | 2 | 2004 | 1165 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2015 | 1480 | 0.020 |
Why?
|
Body Constitution | 1 | 2009 | 273 | 0.020 |
Why?
|
RNA, Untranslated | 1 | 2012 | 453 | 0.020 |
Why?
|
Cytokines | 2 | 2017 | 7386 | 0.020 |
Why?
|
Optic Nerve | 1 | 2012 | 571 | 0.020 |
Why?
|
Proportional Hazards Models | 2 | 2015 | 12474 | 0.020 |
Why?
|
Vision Tests | 1 | 2009 | 160 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2017 | 2549 | 0.020 |
Why?
|
Tissue Array Analysis | 1 | 2010 | 550 | 0.020 |
Why?
|
Protein Conformation | 1 | 2016 | 3933 | 0.020 |
Why?
|
Cell Line, Tumor | 2 | 2018 | 16952 | 0.020 |
Why?
|
Recombination, Genetic | 1 | 2013 | 1518 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 1 | 1995 | 1838 | 0.020 |
Why?
|
Pupil | 1 | 2009 | 145 | 0.020 |
Why?
|
Glucose Clamp Technique | 1 | 2008 | 262 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2015 | 1967 | 0.020 |
Why?
|
Refraction, Ocular | 1 | 2009 | 184 | 0.020 |
Why?
|
HIV-1 | 2 | 1995 | 6851 | 0.020 |
Why?
|
Visual Field Tests | 1 | 2010 | 410 | 0.020 |
Why?
|
Age Factors | 2 | 2015 | 18384 | 0.020 |
Why?
|
DNA, Complementary | 2 | 2004 | 1989 | 0.020 |
Why?
|
Wound Healing | 1 | 2018 | 2800 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2012 | 14675 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 1 | 2015 | 3726 | 0.020 |
Why?
|
Anemia, Sickle Cell | 1 | 2015 | 1063 | 0.020 |
Why?
|
Protein Structure, Tertiary | 2 | 2004 | 3778 | 0.020 |
Why?
|
Amino Acids | 1 | 2013 | 1703 | 0.020 |
Why?
|
Logistic Models | 2 | 2012 | 13249 | 0.020 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2008 | 438 | 0.020 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 2008 | 557 | 0.020 |
Why?
|
Observer Variation | 1 | 2012 | 2610 | 0.020 |
Why?
|
Genes, tat | 2 | 1995 | 15 | 0.020 |
Why?
|
Selection, Genetic | 1 | 2010 | 871 | 0.020 |
Why?
|
Genetic Loci | 1 | 2015 | 2623 | 0.020 |
Why?
|
Hyperinsulinism | 1 | 2008 | 400 | 0.020 |
Why?
|
RNA, Complementary | 1 | 2004 | 45 | 0.020 |
Why?
|
tat Gene Products, Human Immunodeficiency Virus | 2 | 1995 | 118 | 0.020 |
Why?
|
Perfusion | 1 | 2010 | 1390 | 0.020 |
Why?
|
Cause of Death | 1 | 2015 | 3688 | 0.020 |
Why?
|
Chlorine | 1 | 2004 | 55 | 0.010 |
Why?
|
Macular Edema | 1 | 2009 | 374 | 0.010 |
Why?
|
Anions | 1 | 2004 | 133 | 0.010 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 1995 | 2915 | 0.010 |
Why?
|
Chromatography, Ion Exchange | 1 | 2004 | 294 | 0.010 |
Why?
|
Sodium Bicarbonate | 1 | 2004 | 60 | 0.010 |
Why?
|
ROC Curve | 1 | 2012 | 3584 | 0.010 |
Why?
|
Oxalates | 1 | 2004 | 98 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2015 | 4739 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2012 | 4612 | 0.010 |
Why?
|
Reproducibility of Results | 2 | 2012 | 20119 | 0.010 |
Why?
|
Sulfates | 1 | 2004 | 378 | 0.010 |
Why?
|
Adenosine Triphosphatases | 1 | 2008 | 833 | 0.010 |
Why?
|
Survival Rate | 1 | 2017 | 12728 | 0.010 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2015 | 3634 | 0.010 |
Why?
|
Codon | 1 | 2004 | 597 | 0.010 |
Why?
|
Asia | 1 | 2004 | 622 | 0.010 |
Why?
|
Homeodomain Proteins | 1 | 2012 | 2414 | 0.010 |
Why?
|
Blotting, Western | 1 | 2010 | 5032 | 0.010 |
Why?
|
Spectrometry, Fluorescence | 1 | 2004 | 683 | 0.010 |
Why?
|
Probability | 1 | 2008 | 2478 | 0.010 |
Why?
|
Gene Expression | 1 | 2015 | 7571 | 0.010 |
Why?
|
Adipose Tissue, Brown | 1 | 2008 | 766 | 0.010 |
Why?
|
Electrodes | 1 | 2004 | 611 | 0.010 |
Why?
|
Adenosine Triphosphate | 1 | 2008 | 1988 | 0.010 |
Why?
|
Oxygen Consumption | 1 | 2008 | 1867 | 0.010 |
Why?
|
Immunoblotting | 1 | 2004 | 1644 | 0.010 |
Why?
|
Pancreas | 1 | 2008 | 1684 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2004 | 1681 | 0.010 |
Why?
|
Chelating Agents | 1 | 2003 | 383 | 0.010 |
Why?
|
Hepatocytes | 1 | 2008 | 1231 | 0.010 |
Why?
|
Cyclic AMP | 1 | 2004 | 1462 | 0.010 |
Why?
|
Australia | 1 | 2004 | 1246 | 0.010 |
Why?
|
Gene Deletion | 1 | 2008 | 2658 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2018 | 9278 | 0.010 |
Why?
|
Biological Transport | 1 | 2004 | 2080 | 0.010 |
Why?
|
Phosphoproteins | 1 | 2008 | 2444 | 0.010 |
Why?
|
Apoptosis | 1 | 1995 | 9477 | 0.010 |
Why?
|
Microscopy, Confocal | 1 | 2004 | 1967 | 0.010 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2008 | 2871 | 0.010 |
Why?
|
Causality | 1 | 2004 | 1244 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 1995 | 10203 | 0.010 |
Why?
|
Tumor Cells, Cultured | 2 | 1995 | 6124 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2017 | 64681 | 0.010 |
Why?
|
Structure-Activity Relationship | 1 | 2003 | 3057 | 0.010 |
Why?
|
Europe | 1 | 2004 | 3423 | 0.010 |
Why?
|
Energy Metabolism | 1 | 2008 | 2877 | 0.010 |
Why?
|
Imidazoles | 1 | 2003 | 1172 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 11733 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2010 | 11067 | 0.010 |
Why?
|
Smoking | 1 | 2012 | 9055 | 0.010 |
Why?
|
HIV Long Terminal Repeat | 1 | 1995 | 85 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2010 | 11119 | 0.010 |
Why?
|
Cyclin-Dependent Kinase 2 | 1 | 1995 | 182 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 2015 | 11476 | 0.010 |
Why?
|
Glaucoma | 1 | 2004 | 1186 | 0.010 |
Why?
|
Base Sequence | 2 | 1995 | 12404 | 0.010 |
Why?
|
Sex Factors | 1 | 2008 | 10553 | 0.010 |
Why?
|
Acute Disease | 1 | 2004 | 7226 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2008 | 4947 | 0.010 |
Why?
|
Genes, p53 | 1 | 1995 | 713 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2008 | 18926 | 0.010 |
Why?
|
Peptides | 1 | 2004 | 4353 | 0.010 |
Why?
|
Cyclin-Dependent Kinases | 1 | 1995 | 655 | 0.010 |
Why?
|
Algorithms | 1 | 2011 | 14025 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 1995 | 1749 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2004 | 14610 | 0.000 |
Why?
|
Down-Regulation | 1 | 1995 | 2916 | 0.000 |
Why?
|
Quality of Life | 1 | 2009 | 13367 | 0.000 |
Why?
|
Neurons | 1 | 2004 | 9428 | 0.000 |
Why?
|
Promoter Regions, Genetic | 1 | 1995 | 5773 | 0.000 |
Why?
|